The Economic Club of Washington, D.C. is pleased to announce that David Rubenstein will interview David A. Ricks, Chair and Chief Executive Officer of Eli Lilly and Company. The in-person lunch will be held on Tuesday, December 10, 2024. The reception will begin at 11:00 a.m., followed by the lunch and program at 12:00 p.m., ending promptly at 1:30 p.m.
Dave Ricks, a veteran of Eli Lilly and Company for over 25 years, has extensive experience in marketing, sales, drug development, and international operations. He assumed the role of CEO and was elected Chair of the Board of Directors in 2017. Ricks joined Lilly as a business development associate and progressed through various management roles in U.S. marketing and sales before taking on international leadership positions. Under Ricks' leadership, Lilly has achieved record research and development output and business results, positioning the company for robust growth and a broader impact on global health.
Established in 1876, Eli Lilly and Company was founded in Indianapolis, Indiana as a pharmaceutical manufacturing business. Today, Lilly's medications reach over 55 million people worldwide. With a commitment to high-quality medicine and a legacy of innovation, Lilly continues to play a pivotal role in the pharmaceutical industry. The company leverages advancements in biotechnology, chemistry, and genetic medicine to tackle some of the most pressing health challenges, including diabetes, obesity, Alzheimer's disease, cancer, and more.
